SB 844: Sickle Cell Disease Care Management and Treatment Continuing Education
GENERAL BILL by Jones
Sickle Cell Disease Care Management and Treatment Continuing Education; Revising requirements for a continuing education course on prescribing controlled substances which health care practitioners are required to complete; requiring the applicable licensing boards for specified health care professions to require a 2-hour continuing education course on sickle cell disease care management as part of the first licensure or certification renewal; specifying requirements for the course; authorizing the applicable boards to approve additional equivalent courses to satisfy the requirement, etc.
-
Bill History
Date Chamber Action 12/10/2025 Senate • Filed
-
SB 844, Original Filed Version (Current Bill Version) Posted 12/10/2025 at 8:14 AM
Bill Text: Web Page | PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills H 353 Sickle Cell Care Management and Treatment Continuing Education Robinson Identical Last Action: 11/12/2025 H Now in Health Professions & Programs Subcommittee 
Citations - Statutes (2)
Citation Catchline Location in Bill Location In Bill Help 456.0301 Requirement for instruction on controlled substance prescribing. Page 2 (pdf) 456.0311 Page 3 (pdf)